University of Wisconsin–Madison

UW Madison Psychedelic Symposium

Developed & Conducted by the University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances and the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.

The University of Wisconsin Madison Transdisciplinary Center for Research in Psychoactive Substances is pleased to announce our 2021 Psychedelic Symposium, to be offered on November 4th & 5th, 2021.

The Symposium will be held on campus in the Wisconsin Institutes of Discovery DeLuca Forum.  Highlighting scholarly work being performed in this field at the UW-Madison, as well as featuring nationally renowned keynote speakers, this Symposium is intended for researchers and clinicians in the areas of clinical psychology, psychiatry, pharmacy, nursing, and social work and will offer continuing education hours.

The Symposium will include updates on the exploratory use of MDMA in the treatment of PTSD, and psilocybin for depression and substance use disorders. The phenomenology of psychedelic experiences will be discussed, as well as historical, environmental, and cultural implications of the use of traditional psychedelics. Barriers to access to this clinical research that exist for underserved populations will be explored, along with suggestions to address these barriers and expand access in future research.

We hope that you can join the inaugural UW-Madison Psychedelic Symposium.

Session topics include:

  • Psychedelic Wars: Past and Present
  • Psychedelics in Latin America and the case of the Intercultural Clinic in Sonora, Mexico
  • Neuropharmacology of Psychedelic Action
  • Environmental Influences on Psilocybin Outcomes Across Species
  • MDMA Assisted Psychotherapy for PTSD
  • Psilocybin in the Treatment of Addictive Disorders
  • Psychedelics in the Treatment of Depression
  • The Phenomenology of Psychedelics

 

Registration Information

Register

Refund Policy

Course date:Nov 4, 2021 - Nov 5, 2021
Location:

Wisconsin Institutes of Discovery
DeLuca Forum
333 N Orchard Dr
Madison, WI

Course fee:

Registrants requesting CE:

$250 for 2 days 
$125 for 1 day, either Thur Nov 4 or Friday Nov 5

Non CE attendees:

$200 for 2 days 
$100 for one day, either Thur Nov 4 or Friday Nov 5

Grad Students
$50 per day, either Thur Nov 4 or Friday Nov 5

Course Objectives

As a result of participating in this symposium, learners should be able to:

  • Describe the neuropharmacology of psilocybin and MDMA, noting their similaries and differences.
  • Describe the common and rarer but serious adverse effects of psilocybin and MDMA, and other related drugs.
  • Describe the processes of patient selection, preparation, and treatment, and how these are intended to minimize adverse effects and maximize therapeutic benefits.
  • Describe the cultural, historic, and socioeconomic barriers to therapeutic treatments with psychedelics.
  • Describe the steps for developing a drug for FDA approval, and how the process for psilocybin and MDMA is likely to be different from related psychoactive drugs.
  • Describe the different chemical classes of psychedelics, including similarities and differences in effect and time course of effect.

Course Outline

Thursday, November 4, 2021
8:00 am Registration and Continental Breakfast
8:45 am

Welcome and Introductions

Paul Hutson, PharmD, BCOP, Professor, Pharmacy Practice Division, University of Wisconsin-Madison, School of Pharmacy

9:00 am

What in the World is Going on with Psychedelic Research?

Speaker: Paul Hutson, PharmD, BCOP

9:30 am

Psychedelic Wars: Past and Present 

Speaker: Lucas Richert, PhD, Associate Professor,  George Urdang Chair in the History of Pharmacy Director of Graduate Studies, Health Services Research in Pharmacy Graduate Program, University of Wisconsin-Madison, School of Pharmacy

10:00 am Break
10:30 am

Psychedelics in Latin America and the case of the Intercultural Clinic in Sonora, Mexico

Speaker: Alberto Vargas, PhD, Associate Director Latin American, Caribbean and Iberian Studies Program, University of Wisconsin-Madison

11:00 am Junior Presenter
11:30 am Panel Discussion - Paul Hutson, Lucas Richert and Alberto Vargas
12:00 pm Lunch/Networking
 

Afternoon Session

1:00 pm

MDMA-Assisted Psychotherapy for PSTD

Speaker: Christopher Nicholas, PhD, Assistant Professor (CHS), School of Medicine and Public Health

1:30 pm

Keynote Speaker
Classic Psychedelics as Novel Therapeutics for Substance Use Disorders: Special Considerations for Vulnerable Populations

Speaker: Peter S. Hendricks, PhD, (Clinical Psychologist), Professor & Director of Research, Department of Health Behavior, School of Public Health, University of Alabama at Birmingham

2:30 pm

Ketamine in the Treatment of Substance Use Disorders 

Speaker: Chantelle Thomas, PhD,  Research Associate, Department of Family Medicine and Community Health, School of Medicine and Public Health, Madison, Wisconsin, and Executive Clinical Director, Windrose Recovery, Brookfield, Wisconsin

3:00 pm

Break

3:15 pm

Research into Therapeutic Potential of Psychedelics for Substance Use Disorders

Speaker: Randy Brown, MD, PhD, DFASAM, Associate Professor with Tenure, Department of Family Medicine and Community Health; Director, University of Wisconsin Addiction Medicine Fellowship Training Program, University of Wisconsin School of Medicine and Public Health, Staff Addictionologist, HIV Comprehensive Care Center University of Wisconsin Hospital and Clinics
3:45 pm Panel Discussion - Christopher Nicholas, Peter Hendricks, Chantelle Thomas and Randy Brown
4:30 pm Adjourn Day 1
Friday, November 5, 2021
8:00 am

Continental Breakfast

8:45 am

Welcome and Introductions

Paul Hutson, PharmD, BCOP, Professor, Pharmacy Practice Division, University of Wisconsin-Madison, School of Pharmacy


9:00 am

Beyond Mysticism: the Phenomenology of Psychedelics

Speaker: John Dunne, PhD, Distinguished Professor of Contemplative Humanities, Chair Department of Asian Languages & Cultures and Core Faculty, Center for Healthy Minds, University of Wisconsin-Madison

9:30 am

Psychedelic Substances in the Treatment of Depression   

Speaker: Charles L. Raison, MD, Mary Sue and Mike Shannon Distinguished Chair for Healthy Minds, Children & Families, Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison

10:00 am

Networking Break
10:30 am

Keynote Speaker 
Psychedelics and Racial Justice: Equity and Access

Speaker: Monnica Williams, PhD, ABPP, Clinical psychologist, and Associate Professor and Director of the Laboratory for Culture and Mental Health Disparities, School of Psychology, University of Ottawa

11:30 am Panel Discussion - John Dunne, Charles Raison and Monnica Williams
12:00 pm

Lunch and Poster Session

 

Afternoon Session

1:00 pm

From Stress to Self-Identity: Environmental Influences on Psilocybin Outcomes Across Species

Speaker: Cody Wenthur, PharmD, PhD, Assistant Professor and Director, MS in Psychoactive, Pharmaceutical Investigation, University of Wisconsin-Madison School of Pharmacy

1:30 pm

The Short and Long of it: Acute and Post-Acute Effects of Ketamine and Classical Psychedelics on Brain Activity and Connectivity

Speaker: Matthew Banks, PhD, Professor, School of Medicine and Public Health

2:00 pm

Junior Presenter

2:30 pm

Panel Discussion - Cody Wenthur and Matthew Banks

3:00-4:30

Poster session and Reception

   

Instructors

Matthew Banks, PhD, Professor, School of Medicine and Public Health, Madison, WI

Randy Brown, MD, PhD, DFASAM, Associate Professor with Tenure, Department of Family Medicine and Community Health; Director, University of Wisconsin Addiction Medicine Fellowship Training Program, University of Wisconsin School of Medicine and Public Health; Staff Addictionologist, HIV Comprehensive Care Center University of Wisconsin Hospital and Clinics, Madison, Wisconsin

John Dunne, PhD, Distinguished Professor of Contemplative Humanities, Chair Department of Asian Languages & Cultures and Core Faculty, Center for Healthy Minds, University of Wisconsin-Madison, Madison, WI

Peter S. Hendricks, PhD, (Clinical Psychologist), Professor & Director of Research, Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL

Paul Hutson, PharmD, BCOP, Professor, Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI

Christopher Nicholas, PhD, Assistant Professor (CHS), School of Medicine and Public Health, Madison, WI

Charles L. Raison, MD, Mary Sue and Mike Shannon Distinguished Chair for Healthy Minds, Children & Families, Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI

Lucas Richert, PhD, Associate Professor,  George Urdang Chair in the History of Pharmacy Director of Graduate Studies, Health Services Research in Pharmacy Graduate Program, UW Madison School of Pharmacy, Madison, WI

Chantelle Thomas, PhD,  Research Associate, Department of Family Medicine and Community Health, School of Medicine and Public Health, Madison, Wisconsin, and Executive Clinical Director, Windrose Recovery, Brookfield, Wisconsin

Alberto Vargas, PhD, Associate Director Latin American, Caribbean and Iberian   Studies Program, University of Wisconsin-Madison

Cody Wenthur, PharmD, PhD, Assistant Professor and Director, MS in Psychoactive, Pharmaceutical Investigation, University of Wisconsin-Madison School of Pharmacy, Madison, WI

Monnica Williams, PhD, ABPP, Clinical Psychologist, and Associate Professor and Director of the Laboratory for Culture and Mental Health Disparities, School of Psychology, University of Ottawa

Planning Committee

Paul Hutson, PharmD, BCOP, Professor, Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI

Megan Miller, PhD, RN, Postdoctoral Research Associate,  UW-Madison School of Nursing, Madison, WI

Christopher Nicholas, PhD, Assistant Professor (CHS), Clinical Psychologist, School of Medicine and Public Health, Madison, Wi

Charles Raison, MD, Professor, UW-Madison School of Human Ecology, Madison, WI

Lucas Richert, PhD, Associate Professor, Social and Administrative Sciences Division, George Urdang Chair in the History of Pharmacy, Driector of Graduate Studies, Health Services Research in Pharmacy Graduate Program, UW-Madison  School of Pharmacy, Madison, WI

Cody Wenthur, PharmD, PhD, Assistant Professor, Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI

Angela Willits, MSW, LCSW, Clinical Assistant Professor, MSW Program Director, UW-Madison School of Social Work, Madison, WI

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin – Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this activity disclose all relevant financial relationships with commercial interests in order to allow staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.

CE Credit

ICEP LogoAccreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin–Madison ICEP designates this live knowledge based activity for 10.00 hours or 0.10 CEUs of CPE credit. Credit can be earned by successfully completing the activity, the assessment and the evaluation. There will be no partial credit awarded for partial completion.

Live CEU's: ACPE# JA0000358-0000-21-124-L04-P (Day 1: 5.5 hours/0.55 CEU's, Day 2: 4.5 hours/0.45 CEU's)

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 10.0 ANCC contact hours.

American Psychological Association (APA)

Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.

ASWB Approved Continuing Education (ACE) – Social Work Credit

As a Jointly Accredited Organization, the University of Wisconsin–Madison ICEP is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program.  Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Wisconsin–Madison ICEP maintains responsibility for this course. Social workers completing this course receive 10.0 live continuing education credits.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.10 CEUs or 10.0 hours.

Program Coordinator

Eric Buxton, PhD

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 262-2431 FAX
(608) 265-2259
eric.buxton@wisc.edu